Valeo Pharma Inc. (VPHIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026
Valeo Pharma Revenue
Valeo Pharma had revenue of 12.60M CAD in the quarter ending July 31, 2024, a decrease of -10.52%. This brings the company's revenue in the last twelve months to 53.38M, down -0.16% year-over-year. In the fiscal year ending October 31, 2023, Valeo Pharma had annual revenue of 53.91M with 94.31% growth.
Revenue (ttm)
53.38M CAD
Revenue Growth
-0.16%
P/S Ratio
n/a
Revenue / Employee
762.53K CAD
Employees
70
Market Cap
99.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MJardin Group | 4.81M |
| Chalice Brands | 25.96M |
| Allied | 104.81K |
| GSRX Industries | 10.13M |
| Isodiol International | 12.18M |
| TransCanna Holdings | 2.97M |
| Interpharm Holdings | 69.21M |